Success Metrics

Clinical Success Rate

88.9%

Based on 8 completed trials

Completion Rate

89%(8/9)

Active Trials

9(38%)

Results Posted

25%(2 trials)

Terminated

1(4%)

Phase Distribution

Ph phase_4

50%

Ph phase_1

Ph phase_3

Ph not_applicable

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution19 total trials

Phase 1Safety & dosage

1(5.3%)

Phase 3Large-scale testing

2(10.5%)

Phase 4Post-market surveillance

12(63.2%)

N/ANon-phased studies

4(21.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(12)

Completed(8)

Terminated(1)

Other(3)

Detailed Status

Completed8

Recruiting7

unknown3

Enrolling by invitation2

Active, not recruiting2

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

88.9%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (5.3%)

Phase 32 (10.5%)

Phase 412 (63.2%)

N/A4 (21.1%)

Trials by Status

enrolling_by_invitation28%

unknown313%

not_yet_recruiting14%

terminated14%

recruiting729%

completed833%

active_not_recruiting28%

Recent Activity

9 active trials

Showing 5 of 24

recruitingnot_applicable

Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk

NCT07099677

recruitingphase_4

LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

NCT05786417

recruitingnot_applicable

Clinical Trials (24)

Showing 20 of 24 trialsScroll for more

NCT07099677Not Applicable

Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk

Recruiting

NCT05786417Phase 4

LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

Recruiting

NCT07054489Not Applicable

UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF

Recruiting

NCT05019027Phase 4

N-of-1 for Beta-Blockers in Cardiac Amyloidosis

Enrolling By Invitation

NCT05585125Phase 4

A Preliminary Study for INFORMED

Enrolling By Invitation

NCT06993597

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

Recruiting

NCT03504956Not Applicable

Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

Recruiting

NCT03596385Phase 4

TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Completed

NCT05721170Phase 4

Impact of Beta Blockers on TAVI (BETA-TAVI)

Recruiting

NCT06509074Phase 4

Beta-Blockers in Takotsubo Syndrome Study

Not Yet Recruiting

NCT05972785

Long-term Use of CCB and Breast Cancer Risk

Active Not Recruiting

NCT05122780Phase 4

Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).

Active Not Recruiting

NCT06371222Phase 4

Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm

Completed

NCT03686696Phase 4

Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT

Terminated

NCT03871647

Effect of Genetic Polymorphism on the Occurrence of Post-Operative Atrial Fibrillation After CABG

Completed

NCT04575675Phase 4

Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy

Completed

NCT04485988

Influence of Beta Blockers on Prognosis in Patients With Acute Myocardial Infarction Complicated With Normal Ejection Fraction

Unknown

NCT04286399Phase 4

Asian Diabetes Outcomes Prevention Trial

Recruiting

NCT03361280Phase 1

Removal of Beta Blocker Drugs by Hemodialysis

Completed

NCT00241904Phase 4

Reducing Total Cardiovascular Risk in an Urban Community

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 24